moxifloxacin has been researched along with cefmenoxime in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (cefmenoxime) | Trials (cefmenoxime) | Recent Studies (post-2010) (cefmenoxime) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 361 | 28 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayaki, M; Iwasawa, A; Niwano, Y | 1 |
Ohashi, Y; Suzuki, T | 1 |
Eguchi, H; Hotta, F; Ishimaru, M; Kogiso, M; Kusaka, S; Nishimura, K; Shimomura, Y; Yaguchi, T | 1 |
3 other study(ies) available for moxifloxacin and cefmenoxime
Article | Year |
---|---|
In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cefmenoxime; Cell Line; Cell Survival; Conjunctiva; Cornea; Dibekacin; Dose-Response Relationship, Drug; Epithelial Cells; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Preservatives, Pharmaceutical; Quinolines; Rabbits | 2012 |
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin | 2013 |
A super-infection in the cornea caused by Stemphylium, Acremonium, and α-Streptococcus.
Topics: Acremonium; Aged; Anti-Infective Agents; Cefmenoxime; Coinfection; Cornea; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Moxifloxacin; Saccharomycetales; Streptococcus | 2017 |